However, so far, only the expression of programmed cell death ligand-1 (PD-L1) on cancer cells as well as a high tumor mutational burden has been found to show a positive predictive value for the efficacy of either PD-1 or PD-L1 inhibitors [6–12]. Here, CD274 is linked to neoplasm.